Journalartikel
Autorenliste: Bretzel, RG; Brendel, M; Eckhard, M; Brandhorst, D; Jaeger, C; Hatziagelaki, E; Federlin, K
Jahr der Veröffentlichung: 2001
Seiten: S384-S399
Zeitschrift: Experimental and Clinical Endocrinology & Diabetes
Bandnummer: 109
ISSN: 0947-7349
eISSN: 1439-3646
DOI Link: https://doi.org/10.1055/s-2001-18597
Verlag: Thieme Publishing
Abstract:
Beta-cell replacement either by pancreatic organ or islet cell transplantation is the only treatment to achieve an insulin-independent, normoglycemic state and to avoid hypoglycemic episodes in patients with type 1 diabetes mellitus, This article will review the state-of-the-art in clinical islet cell personal experience. transplantation at the dawn of the new millenium and will provide an outlook on the basis of extended personal experience.
Zitierstile
Harvard-Zitierstil: Bretzel, R., Brendel, M., Eckhard, M., Brandhorst, D., Jaeger, C., Hatziagelaki, E., et al. (2001) Islet transplantation: Present clinical situation and future aspects, Experimental and Clinical Endocrinology & Diabetes, 109, pp. S384-S399. https://doi.org/10.1055/s-2001-18597
APA-Zitierstil: Bretzel, R., Brendel, M., Eckhard, M., Brandhorst, D., Jaeger, C., Hatziagelaki, E., & Federlin, K. (2001). Islet transplantation: Present clinical situation and future aspects. Experimental and Clinical Endocrinology & Diabetes. 109, S384-S399. https://doi.org/10.1055/s-2001-18597
Schlagwörter
ACID DECARBOXYLASE ANTIBODIES; ALLOGRAFT SURVIVAL; alloimmunity; AUTOIMMUNITY; CELL ANTIBODIES; DIABETES-MELLITUS; DONOR; Gene therapy; immunotolerance; INSULIN INDEPENDENCE; ISLET TRANSPLANTATION; Kidney transplantation; LONG-TERM SURVIVAL; PANCREATIC-ISLET